Supplementary Figure 10: Differential AE risks among population subgroups as a function of indication, demographic, and the use of NSAIDs or coxibs. | Nature Biotechnology

Supplementary Figure 10: Differential AE risks among population subgroups as a function of indication, demographic, and the use of NSAIDs or coxibs.

From: Data mining differential clinical outcomes associated with drug regimens using adverse event reporting data

Supplementary Figure 10

AERSMine-facilitated clinical indications based construction and grouping of patient subsets showing differential AE risks in management of pain, arthritis and hypertension. Detection of differential risk patterns across similar clinical indication demographic subgroups allows for improved hypothesis generation of alternative therapeutic regimens.

Back to article page